Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer’s Disease

Cited by (222)

Items 201–222 of 222

1. WNT/? CATENIN PATHWAY MODULATORS IN SYNAPTIC REMODELING- PROMISING THERAPEUTIC AGENTS FOR ALZHEIMER’S DISEASE
   2023 · International Journal of Biology Pharmacy and Allied Sciences
2. PARTICIPAÇÃO DA VIA DE SINALIZAÇÃO WNT NA DEMÊNCIA E SUA RELAÇÃO COM O DIABETES TIPO 3
   Paola Sossai Aguiar, Estevão Carlos Silva Barcelos, Izadora Silveira Fernandes, Alda dos Santos Rodrigues, Michel Satya Naslavsky, C. M. C. Maranduba, Flavia Paula, Maria Rita Passos‐Bueno, Mayana Zatz, Flávia Imbroisi Valle Errera · 2023 · Editora Científica Digital eBooks
3. Envelhecimento Humano e Contemporaneidade: tópicos atuais em pesquisa - Volume 3
   Silva, Larissa Vasconcelos, Santos, Amanda Cibelle Gaspar dos, Ferreira, Mirela Argolo, Reis, Renata Pacheco, Santos, Getisêmani Kundsen Menezes, Nascimento, Éddio Dantas do, Matos, Idaclece Rodrigues de, Silva, Janete Pereira Cirilo da, Almeida, Paulo César de, Dias, Susana Teixeira et al. · 2023 · Editora Científica Digital eBooks
4. Common Signaling Pathways in Cancer and Alzheimer's Disease May Point to New Treatments
   Chenglong Wu, Leyao Jiang, Ying Zhong, Zongliang Liu · 2025 · Current Topics in Medicinal Chemistry
5. The Role of Adult Hippocampal Neurogenesis in Alzheimer's Disease: Mechanisms, Therapeutic Potential, and Future Directions
   Jingyi Yang · 2025 · Theoretical and Natural Science
6. Mapping the Brain’s Role in Osteoarthritis: New Evidence for Prevention
   Jingkai Di, Yujia Xi, Yaru Liu, Likun Qi, Shuai Chen, Yingda Qin, Chuan Xiang · 2025 · Journal of Multidisciplinary Healthcare
7. Inference of Cell-Cell Communication to Understand the Molecular Mechanisms of Alzheimer's Disease
   Adrita Samanta, Na Sun, M Kellis · 2025
8. Genome-wide association study identifies novel variants in olfactory, vitamin A, vitamin B, and cadherin pathways associated with learning and memory
   Lloyd N. Hopkins, Nesli Avgan, Heidi G. E. Sutherland, Francesca Fernandez, Emma E. M. Knowles, Larisa Margaret Haupt, John Blangero, David C. Glahn, David Shum, Rod A. Lea et al. · 2025 · Scientific Reports
9. Additional file 1 of Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus)
   Yuta Takaichi, Chambers, James K., Takahashi, Kei, Yoshiyuki Soeda, Riki Koike, Etsuko Katsumata, Chiaki Kita, Matsuda, Fuko, Haritani, Makoto, Takashima, Akihiko et al. · 2021 · Figshare
10. Omega-3 polyunsaturated fatty acids mitigate working memory decline through feeding a low-carbohydrate and high-protein diet in healthy mice
    Takeru Shima, Daichi Hirose · 2026 · Prostaglandins Leukotrienes and Essential Fatty Acids
11. Implications de la protéine DYRK1A dans la pathologie Alzheimer et développement de stratégies thérapeutiques
    Benoît Souchet · 2018 · theses.fr (ABES)
12. Impact du variant rare pVal667Met de LRP5 sur le phénotype osseux et oculaire chez l'homme et dans un modèle expérimental
    Stéphanie Fabre · 2021 · theses.fr (ABES)
13. Romosozumab versus teriparatide for risk of dementia in individuals with osteoporosis: a target trial emulation study
    Masaki Hatano, Akira Okada, Yusuke Sasabuchi, Yuya Kimura, So Sato, Hisatoshi Ishikura, Takeyuki Tanaka, Taku Saito, Sakae Tanaka, Hideo Yasunaga · 2026 · Osteoporosis International
14. Discovery of a CI-994 derivative as a dual modulator of class I HDACs and Wnt/β-catenin signaling for Alzheimer’s disease therapy
    Wenyan Lü, Thomas R. Caulfield, Eunmi Lee, Suren Jeevaratnam, Ni Wang, Guojun Bu, Takahisa Kanekiyo, Yonghe Li · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
15. In silico and in vitro evaluation of risedronate as a DKK1 antagonist: Implications for neuroprotection through DKK1–LRP6 modulation
    Suman Manandhar, Anusha Govindula, Kokou Atchou, Ajmal Nassar, Shama Prasada Kabekkodu, Karkala Sreedhara Ranganath Pai · 2026 · European Journal of Pharmacology
16. Overexpression of WNT3a in the Hippocampus Can Partly Alleviate Deficits in Animal Models of Alzheimer’s Disease
    Konstantin A. Gerasimov, Yuliana E. Ignasheva, Yulia V. Dobryakova, Tinna Korotkova, Alena Koryagina, Vladimir A. Markevich, Alexey P. Bolshakov · 2026 · Neurochemical Research
17. Glycogen Synthase Kinase-3β Inhibition Ameliorates Synaptic and Mitochondrial Dysfunction in a Sporadic Alzheimer’s Disease–Like Model
    Yahan Wang, Peng‐Li Ding, Hao Qin, Kai-Xin Zhang, Jin-wen Ge, Dahua Wu, Le Xie, Kun Liang · 2026 · Molecular Neurobiology
18. Discovery of a CI-994 derivative as a dual modulator of class I histone deacetylases and Wnt/β-catenin signaling for Alzheimer’s disease therapy
    Wenyan Lu, Thomas R. Caulfield, Eunmi Lee, Suren Jeevaratnam, Ni Wang, Guojun Bu, Takahisa Kanekiyo, Yonghe Li · 2026 · Neurotherapeutics
19. Distinct single‐nucleus RNA‐seq changes among non‐neuronal cells in ADNC, LATE‐NC, and mixed pathologies
    Qi Qiao, Yuriko Katsumata, Hsin-Yu Lai, Kevin Z. Lin, Steven A. Claas, Mariano I. Gabitto, Josh M. Morganti, Peter T. Nelson, Shubhabrata Mukherjee, David W. Fardo · 2026 · Alzheimer s & Dementia
20. Osteoporosis and Alzheimer’s Disease: The Role of Sclerostin
    Lorelé Gagiano, Ziming Chen, William G. Blakeney, Christopher Wynne Jones, Frank Mastaglia, 郑铭豪, Jun Yuan · 2026 · Current Osteoporosis Reports
21. BindingDB Entry 50010472: Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitors.
    BindingDB · 2021 · UC San Diego
22. Wnt/β-catenin signaling dysregulation in Alzheimer’s disease and therapeutic opportunities
    Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Aseel F. Al-Gharaibeh, Amal Kaddoumi · 2026 · Biomedicine & Pharmacotherapy